BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 15999349)

  • 1. Comparisons of outcomes and survivals for two central venous access port systems.
    Hou SM; Wang PC; Sung YC; Lee HH; Liu HT; Chen YH
    J Surg Oncol; 2005 Jul; 91(1):61-6. PubMed ID: 15999349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is guidewire exchange a better approach for subclavian vein re-catheterization for chronic hemodialysis patients?
    Hou SM; Chou PC; Huang CH; Chin CH; Wang PC; Chen YH
    Thromb Res; 2006; 118(4):439-45. PubMed ID: 16214203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of thrombosis and infections of central venous catheters and totally implanted access ports in patients treated for cancer.
    Beckers MM; Ruven HJ; Seldenrijk CA; Prins MH; Biesma DH
    Thromb Res; 2010 Apr; 125(4):318-21. PubMed ID: 19640573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The timing and sequence of multiple device-related complications in patients with long-term indwelling Groshong catheters.
    Tolar B; Gould JR
    Cancer; 1996 Sep; 78(6):1308-13. PubMed ID: 8826955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival and complications of indwelling venous catheters for permanent use in hemodialysis patients.
    Develter W; De Cubber A; Van Biesen W; Vanholder R; Lameire N
    Artif Organs; 2005 May; 29(5):399-405. PubMed ID: 15854216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Externalized Groshong catheters and Hickman ports for central venous access in gynecologic oncology patients.
    Gleeson NC; Fiorica JV; Mark JE; Pinelli DM; Hoffman MS; Roberts WS; Cavanagh D
    Gynecol Oncol; 1993 Dec; 51(3):372-6. PubMed ID: 8112648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Groshong versus Hickman catheters.
    Pasquale MD; Campbell JM; Magnant CM
    Surg Gynecol Obstet; 1992 May; 174(5):408-10. PubMed ID: 1570619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infectious port complications are more frequent in younger patients with hematologic malignancies than in solid tumor patients.
    Samaras P; Dold S; Braun J; Kestenholz P; Breitenstein S; Imhof A; Renner C; Stenner-Liewen F; Pestalozzi BC
    Oncology; 2008; 74(3-4):237-44. PubMed ID: 18716418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized, prospective trial of standard Hickman compared with Groshong central venous catheters in pediatric oncology patients.
    Warner BW; Haygood MM; Davies SL; Hennies GA
    J Am Coll Surg; 1996 Aug; 183(2):140-4. PubMed ID: 8696545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do central venous catheters have advantages over arteriovenous fistulas or grafts?
    Quarello F; Forneris G; Borca M; Pozzato M
    J Nephrol; 2006; 19(3):265-79. PubMed ID: 16874685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tunneled internal jugular catheters in adult patients: comparison of outcomes in hemodialysis versus infusion catheters.
    Peynircioglu B; Ozkan F; Canyigit M; Cil BE; Balkanci F
    Acta Radiol; 2007 Jul; 48(6):613-9. PubMed ID: 17611867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term Tesio catheter access for hemodialysis can deliver high dialysis adequacy with low complication rates.
    Power A; Singh SK; Ashby D; Cairns T; Taube D; Duncan N
    J Vasc Interv Radiol; 2011 May; 22(5):631-7. PubMed ID: 21419650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prospective monitoring of vascular access in hemodialysis by means of a multidisciplinary team].
    Gruss E; Portolés J; Jiménez P; Hernández T; Rueda JA; del Cerro J; Lasala M; Tato A; Gago MC; Martínez S; Velayos P
    Nefrologia; 2006; 26(6):703-10. PubMed ID: 17227248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Long-term central venous lines and their complications].
    Teichgräber UK; Gebauer B; Benter T; Wagner J
    Rofo; 2004 Jul; 176(7):944-52. PubMed ID: 15237335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inserting tunnelled hemodialysis catheters using elective guidewire exchange from nontunnelled catheters: is there a greater risk of infection when compared with new-site replacement?
    Casey J; Davies J; Balshaw-Greer A; Taylor N; Crowe AV; McClelland P
    Hemodial Int; 2008 Jan; 12(1):52-4. PubMed ID: 18271841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Tesio twin catheter system for hemodialysis tunnelized using an echo-guided technique. Retrospective analysis of 210 catheters].
    Ibrik O; Samon R; Roca R; Viladoms J; Mora J
    Nefrologia; 2006; 26(6):719-25. PubMed ID: 17227250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of catheter type on the functional survival of jugular access ports in chronic hemodialysis].
    Chazot C; Charra B; Vanel T; Jean G; Laurent G
    Nephrologie; 1994; 15(2):77-9. PubMed ID: 8047220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complications associated with an implantable vascular access device.
    Dillon PA; Foglia RP
    J Pediatr Surg; 2006 Sep; 41(9):1582-7. PubMed ID: 16952595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for early catheter-related infections in cancer patients.
    Penel N; Neu JC; Clisant S; Hoppe H; Devos P; Yazdanpanah Y
    Cancer; 2007 Oct; 110(7):1586-92. PubMed ID: 17685401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Higher complication risk of totally implantable venous access port systems in patients with advanced cancer - a single institution retrospective analysis.
    Chang YF; Lo AC; Tsai CH; Lee PY; Sun S; Chang TH; Chen CC; Chang YS; Chen JR
    Palliat Med; 2013 Feb; 27(2):185-91. PubMed ID: 22126844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.